Early Access Programs
With a truly patient-focused approach, we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
With a truly patient-focused approach, we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Our Early Access Programs (often called Expanded Access, Pre-approval Access, Compassionate Use, Named Patient or Managed Access Programs) deliver potentially life-saving treatments to patients around the world while adding true value to our clients through a range of additional cutting-edge services.
Patients are at the heart of everything we do. Our vision is to help current and future generations by providing timely and appropriate treatment access to patients in desperate need.
We provide in-house, highly specialized and EAP centric clinical services, including dedicated Real-World Evidence, Pharmacovigilance and Medical teams to support all program requirements. Our vast experience in oncology and rare disease, and dedicated EAP teams and processes, are essential to providing innovative EAP solutions to pharma and biotech companies globally.
